Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
2001
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.
2000
Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of HER-2/neu in Breast Cancer
1999
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
1997 Standout
Acromegaly
2006 Standout
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3β
2004
Cell-cycle checkpoints and cancer
2004 StandoutNature
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
1999 Standout
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
1998
c-Myc-regulated microRNAs modulate E2F1 expression
2005 StandoutNature
Choosing anticancer drug targets in the postgenomic era
1999 StandoutNobel
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Molecular defects in the pathogenesis of pituitary tumours
2003
Genetic instabilities in human cancers
1998 StandoutNature
S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer
1998
The role of transforming growth factor Β in glioma progression
1998
Vitamin D Deficiency
2007 Standout
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
1996 StandoutNature
Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population
2001
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions
1999
Global cancer statistics
2011 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Molecular Epidemiology of Vitamin D Receptor Gene Variants
2000
Chk1 is haploinsufficient for multiple functions critical to tumor suppression
2004
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.
1996
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
1996
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Epidemiology — identifying the causes and preventability of cancer?
2005
TGFβ in Cancer
2008 Standout
Molecular portraits of human breast tumours
2000 StandoutNature
Determination of microsatellite instability,p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: Relationship with response to 5-fluorouracil and survival
2001
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
Approaches to Evaluating the Association of Vitamin D Receptor Gene Polymorphisms with Breast Cancer Risk
2003
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
p53 regulation by post-translational modification and nuclear retention in response to diverse stresses
1999
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
2007
Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter "RASCAL" Study
1998
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
1995 Standout
Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis
2001
Autophagy and human diseases
2013
Defects in the Ubiquitin Pathway Induce Caspase-independent Apoptosis Blocked by Bcl-2
1998 StandoutNobel
Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin.
2001
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
The Fgf Family of Growth Factors and Oncogenes
1992
Response to Cyclophosphamide, Methotrexate, and Fluorouracil in Lymph Node–Positive Breast Cancer According to HER2 Overexpression and Other Tumor Biologic Variables
2001
Mechanisms of DNA Excision Repair
1994 StandoutScienceNobel
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Cancer Cell Cycles
1996 StandoutScience
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
2000
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
Fine-Needle Aspiration Cytology of the Thyroid: A 12-Year Experience With 11,000 Biopsies
1993
The Role of Vitamin D in Cancer Prevention
2005 Standout
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
2000 StandoutScience
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
Adolescence: a foundation for future health
2012 Standout
Variants of the VDR gene and Risk of Colon Cancer (United States)
2001
Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas.
2001
Global cancer statistics, 2012
2015 Standout
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
The Molecular Biology of Axon Guidance
1996 StandoutScience
Specificity of HercepTest in Determining HER-2/neu Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System
1999
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
2004 StandoutScience
Works of Sten Wingren being referenced
Suramin inhibits growth of human osteosarcoma xenografts in nude mice.
1991
c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer
1995
C-erbB-2 overexpression and survival in early onset breast cancer
2000
P53 Expression and the Result of Adjuvant Therapy of Breast Cancer
1995
Frequent allelic losses on chromosome 13q in human male breast carcinomas
1997
S-phase fraction is a prognostic factor in stage I breast carcinoma.
1993
Simultaneous analysis of c‐erbB‐2 expression and DNA content in breast cancer using flow cytometry
1994
Candidate tumour suppressor genes at 11q23–q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis
2001
Frequent allelic losses at 11q24.1–q25 in young women with breast cancer: association with poor survival
1999
p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients
2006
Ras P21 Expression in Relation to Histopathological Variables and Prognosis in Colorectal Adenocarcinoma
1991
S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer
1994
A Comparative Study of DNA Cytometry Methods for Benign and Malignant Thyroid Tissue
1988
Association betweenCYP17 gene polymorphism and risk of breast cancer in young women
1999
Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group.
1999
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
1992
DNA index and S-phase in primary brain tumors
1994